~~<i id='5F2327154E'><strike id='5F2327154E'><tt id='5F2327154E'><pre id='5F2327154E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：fashion 2025-10-02 06:19:02 - browse：373

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Living with Hashimoto's and celiac disease, and med school, too

focus

hotspot

leisure time

entertainment

leisure time

MikeReddyforSTATIwasrecentlyworkingwithayoungmotherwhostruggledwithdepressionandanxietyinthedifficul

WSS

Cancer drug shortages' outsize impact on ovarian cancer patients

Baltimore teen accused of firing into crowd during block party mass shooting

Trump's false claims about Georgia's 2020 election long debunked

Trump cancels press conference intended to dispute Georgia election interference charges

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

Neuroscience’s long legacy of racism

hotspot

fashion

focus

Activists slam private health insurers over coverage restrictions

Asbestos, a deadly carcinogen, banned by EPA

Medical records are filled with copy

Trump's false claims about Georgia's 2020 election long debunked

Hepatitis C has a cure — but many Americans still lack access to it

The pain doctors face in trying to build their families

The high cost of giving birth even with insurance

Physicians and social media: If you see something, say something?

Virginia high school admissions case could be legal follow

Ukraine taking heavy casualties 10 weeks into its counteroffensive

hotspot

Physicians and social media: If you see something, say something?

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Majority of Americans think Trump's Ga. election interference case is serious: POLL

5 to watch: Tech startups trying to solve health care's staffing crisis

Virtual Event: March of the Biosimilars

Congress must give Medicare recipients genetic counseling access

hotspot

leisure time

entertainment

leisure time